CAC
WST icon

Cowen and Company’s West Pharmaceutical WST Stock Holding History

Cowen and Company’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,156
Closed -$284K – 735
2022
Q3 		$284K Buy
+1,156
New +$352K 0.03% 152
2022
Q2 		– Sell
-1,186
Closed -$487K – 761
2022
Q1 		$487K Buy
1,186
+387
+48% +$152K 0.05% 163
2021
Q4 		$375K Buy
+799
New +$344K 0.03% 252

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cowen and Company's WST Position: Q4 2022 in Review

Cowen and Company sold out of West Pharmaceutical (WST) in Q4 2022, closing a stake of 1,156 shares — an estimated $284K sold.

Cowen and Company first reported a position in WST in Q4 2021 and held it in 3 quarters. The position peaked at $487K in Q1 2022. 637 funds tracked by Wall St. Rank hold WST as of Q4 2022.

  • Cowen and Company reported no remaining West Pharmaceutical position as of Q4 2022 after selling out during the quarter.
  • Cowen and Company sold 1,156 West Pharmaceutical shares in Q4 2022, an estimated $284K.
  • Cowen and Company first reported a position in West Pharmaceutical in Q4 2021 and held it in 3 quarters.
  • Cowen and Company's West Pharmaceutical position peaked at $487K in Q1 2022.
  • 637 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2022.

Based on Cowen and Company's 13F filing for Q4 2022, filed 9 Feb 2023.